Company / R&D Expense
Lucid Diagnostics Inc. R&D Expense History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$7.3M
FY2024
5-year range
$5.4M / $11.3M
FY2021-FY2024
Trend
-35.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $9M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2024 with a 3-year CAGR of +10.0%.
Declined from $9M to $7M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +10.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +10.0%, indicating consistent growth.
- In FY2024, r&d expense decreased 35.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.3M | -35.6% |
| FY2023 | $11.3M | +21.1% |
| FY2022 | $9.3M | +70.8% |
| FY2021 | $5.4M | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026